Palo Alto, California – Centrillion Technologies, a leading genomic technology company developing and commercializing transformative genomic analysis tools, announced that Mr. Michael Henry has joined the company as Senior Vice President and General Manager Consumer Genomics. Mr. Henry brings over twenty years of senior leadership experience in biotechnology business development.
Prior to joining Centrillion, Mr. Henry served as Vice President Business Development at Ancestry, Quest Diagnostics, Athena Diagnostics and Avant Immunotherapeutics. Prior to Avant, he worked in academic medical centers, serving as Senior Director Licensing and Ventures at University of Massachusetts Medical School, and Director Technology Transfer at Children’s Hospital of Philadelphia. Prior to CHOP, he served as Manager New Business Development at Allelix, Mississauga, Ontario.
Recognized as a National Science Foundation Graduate Fellow as a PhD student at University of California Berkeley, Mr. Henry has an MBA and an MA Botany from University of California Berkeley and a BS Botany from University of Michigan.
About Centrillion Technologies
Centrillion Technologies is enabling scientists to decode and analyze the full genome and helping them power breakthroughs across a multitude of previously unapproachable applications in human health, agriculture and environmental studies. Leveraging the latest advances in engineering and biochemistry, the company’s products and services can isolate, manipulate, visualize, and analyze intact kilobase and megabase fragments of DNA, all with an accurate, simple and affordable workflow. Founded in 2009, Centrillion is led by former Affymetrix executives, backed by leading venture capital and strategic investors and is headquartered in the center of innovation of Silicon Valley in Palo Alto, Calif. near Stanford University. For more information, please visit: www.CentrillionTech.com.
Sard Verbinnen & Co
Megan Bouchier/David Isaacs